Governance and Funding
All.Can Canada, launched in 2018, is a multi-stakeholder initiative under Save Your Skin Foundation. All the publications produced under the initiative reflect the consensus of All.Can Canada members who have full editorial control.
All.Can Canada initiative is made possible with financial support from Bristol Myers Squibb Canada (main sponsor), Merck, Johnson & Johnson, AstraZeneca, Pfizer, Amgen, Novartis and Medison.
Structures and Roles
Steering Committee: Strategic stewards and champions of ACC; multi-stakeholder and patient-led (meet quarterly)
Working Groups: Action-oriented on implementation of strategic action plan; created and dissolved based on need or opportunities; leads/chairs are cross-appointed with Steering Committee (meet on as-needed basis, no more than monthly)
Secretariat: Ensuring shared vision and strategic action plan established and adapted; supporting aligned activities; establishing shared measurement and continuous communication; cultivating ecosystem ownership and engagement; advancing policy; and mobilizing resources
Enablers
• Simple agreements (i.e., Terms of Reference)
• Collaborative leadership with patient partnership
• Secretariat for backbone support functions
Working Groups
Equity Learning Modules for Earlier Cancer Diagnosis: Using co-design, narrative oncology, and digital storytelling to reveal inequities, the project focuses on the experiences of people from diverse communities with late cancer diagnoses and the providers serving them, addressing structural barriers to healthcare.
Ocular Melanoma Research: This committee is already operational, with an IRB-approved research plan in progress, and welcomes new members to provide feedback on the draft analysis and report to understand the diagnostic experiences of patients with ocular melanoma.
Pathways: Co-creating and encouraging adoption/adaptation of symptom pathways, which support primary care providers to more rapidly initiate investigation for a possible cancer. Work with All.Can International on personalized care pathways.
Case Studies: Support the continued production of new case studies to highlight evaluated practices that improve swift, accurate, equitable, and appropriately delivered cancer diagnoses, using ACC’s existing methodology. Members are needed to review/provide feedback on draft case studies as they are developed.